Antiviral Drugs: From Basic Discovery Through Clinical by Wieslaw M. Kazmierski

By Wieslaw M. Kazmierski

This e-book makes a speciality of new small molecule methods to wrestle viral infections. The chapters describe the invention and improvement from bench throughout the health facility of fairly recently-approved antiviral medications and compounds in complex scientific improvement. prepared via a virulent disease (such as HIV, HCV, RSV, influenza, HBV and CMV) and written through most sensible educational and commercial specialists within the box, the ebook presents a distinct chance to check, comprehend and observe discovery and improvement ideas and studying with out the necessity for anyone to investigate, learn and synthesize all significant sourcing references.  subject matters show off demanding situations and suggestions of concerns encountered, offering tremendous event gathered over decades of analysis that would be really worthy to easy and bench scientists in addition to clinicians as they proceed getting to know and constructing new medicinal drugs and treatments.

Show description

Read or Download Antiviral Drugs: From Basic Discovery Through Clinical Trials PDF

Similar pharmacology books

Case Files: Pharmacology (Lange Case Files), 2nd edition

Actual lifestyles scientific circumstances for the fundamental Sciences and USMLE Step 1 you wish publicity to scientific situations to move path checks and ace the USMLE Step 1. Case documents: Pharmacology provides fifty three real-life scientific instances that illustrate crucial recommendations in pharmacology. each one case contains an easy-to-understand dialogue correlated to key easy technological know-how thoughts, definitions of key phrases, pharmacology pearls, and USMLE-style overview questions.

Therapeutic protein drug products: Practical approaches to formulation in the laboratory, manufacturing, and the clinic

Advertisement healing protein drug items; A formula option to increase the actual balance of macromolecular-based drug items; homes of protein formulations; fabric and approach compatibility checking out; Compounding and filling: Drug substance to drug product; management within the health center; Regulatory guidance for the advance of a biotechnology drug product

Extra resources for Antiviral Drugs: From Basic Discovery Through Clinical Trials

Example text

Pharmacol. 2000, 32, 135–143. [14] Butterworth, B. ; Conolly, R. ; Morgan, K. T. A strategy for establishing mode of action of chemical carcinogens as a guide for approaches to risk assessments. Cancer Lett. 1995, 93, 129–146. [15] Gold, L. ; Slone, T. ; Stern, B. ; Bernstein, L. Comparison of target organs of carcinogenicity for P1: TIX/XYZ JWBS061-01 P2: ABC JWBS061-Kazmierski 16 [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] May 24, 2011 16:56 Printer Name: Yet to Come DISCOVERY AND DEVELOPMENT OF ATAZANAVIR mutagenic and non-mutagenic chemicals.

Pathol. 1996, 48, 189–195. [12] Williams, G. ; Iatropoulos, M. ; Weisburger, J. H. Chemical carcinogen mechanisms of action and implications for testing methodology. Exp. Toxicol. Pathol. 1996, 48, 101–111. [13] Lima, B. ; Van der Laan, J. W. Mechanisms of nongenotoxic carcinogenesis and assessment of the human hazard. Regul. Toxicol. Pharmacol. 2000, 32, 135–143. [14] Butterworth, B. ; Conolly, R. ; Morgan, K. T. A strategy for establishing mode of action of chemical carcinogens as a guide for approaches to risk assessments.

Steady state is reached by around day 6 with once-daily dosing. Nonlinear pharmacokinetics were demonstrated, resulting in greater than dose-proportional increases in bioavailability over a dose range of 200 to 800 mg daily in HIV-uninfected subjects [24]. Administration of atazanavir with food enhances its bioavailability and reduces pharmacokinetic variability [25, 26]. The absolute oral bioavailability of atazanavir was not determined in humans; however, the bioavailability of atazanavir capsules relative to a solution was 68% in humans.

Download PDF sample

Rated 4.98 of 5 – based on 38 votes